SOD1 Plasma Level as a Biomarker for Therapeutic Failure in Cutaneous Leishmaniasis
Open Access
- 7 February 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 210 (2) , 306-310
Abstract
We show that increased plasma superoxide dismutase 1 (SOD1) levels are statistically significant predictors of the failure of pentavalent antimony treatment for cutaneous leishmaniasis caused by Leishmania braziliensis. In Leishmania amazonensis–infected patients, host SOD1 levels can be used to discriminate between localized and drug-resistant diffuse cutaneous leishmaniasis. Using in situ transcriptomics (nCounter), we demonstrate a significant positive correlation between host SOD1 and interferon α/β messenger RNA (mRNA) levels, as well as interkingdom correlation between host SOD1 and parasite SOD2/4 mRNA levels. In human macrophages, in vitro treatment with SOD1 increases the parasite burden and induces a diffuse cutaneous leishmaniasis–like morphology. Thus, SOD1 is a clinically relevant biomarker and a therapeutic target in both localized and diffuse cutaneous leishmaniasis.Keywords
This publication has 15 references indexed in Scilit:
- IFN-β Impairs Superoxide-Dependent Parasite Killing in Human Macrophages: Evidence for a Deleterious Role of SOD1 in Cutaneous LeishmaniasisThe Journal of Immunology, 2009
- Clinical and Parasite Species Risk Factors for Pentavalent Antimonial Treatment Failure in Cutaneous Leishmaniasis in PeruClinical Infectious Diseases, 2008
- Cutaneous leishmaniasisThe Lancet Infectious Diseases, 2007
- Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13–15 June, 2006Kinetoplastid Biology and Disease, 2007
- Diffuse cutaneous leishmaniasis responds to miltefosine but then relapsesBritish Journal of Dermatology, 2007
- Advances in leishmaniasisThe Lancet, 2005
- Leishmaniasis: current situation and new perspectivesComparative Immunology, Microbiology and Infectious Diseases, 2004
- Iron Superoxide Dismutases Targeted to the Glycosomes ofLeishmania chagasiAre Important for SurvivalInfection and Immunity, 2003
- Erythrocyte antioxidative enzyme activities and lipid peroxidation levels in patients with cutaneous leishmaniasisParasite, 2003
- Role of superoxide dismutase in survival of Leishmania within the macrophageBiochemical Journal, 2003